Calcium Channel Blockers - Dihydropyridine, Oral

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Status
Current Drug Use Criteria New Drug Evaluation
amlodipine besylate NORVASC TABLET Y    
amlodipine besylate AMLODIPINE BESYLATE TABLET Y    
nicardipine HCl NICARDIPINE HCL CAPSULE Y    
nifedipine NIFEDIPINE ER TAB ER 24 Y    
nifedipine PROCARDIA XL TAB ER 24 Y    
nifedipine NIFEDIPINE ER TABLET ER Y    
amlodipine benzoate KATERZIA ORAL SUSP N    
amlodipine besylate NORLIQVA SOLUTION N    
felodipine FELODIPINE ER TAB ER 24H N    
isradipine ISRADIPINE CAPSULE N    
levamlodipine maleate LEVAMLODIPINE MALEATE TABLET N    
nifedipine NIFEDIPINE CAPSULE N    
nisoldipine NISOLDIPINE TAB ER 24H N    
nisoldipine SULAR TAB ER 24H N    
amlodipine besylate AMLODIPINE BESYLATE TABLET